Speakers

Mark Milton-Edwards


Head of Health Solutions - Digital Health - Teva Pharmaceuticals



Mark is responsible for the Respiratory Health Solutions within Digital Health at TEVA Pharmaceuticals. Over fourteen years with TEVA and prior to that sixteen with AstraZeneca. Mark has held various positions including R&D Project Leader, VP Sales & Marketing, Strategic Planning & Business Development, and Global Brand Lead. Graduated in Aeronautical Sciences and completed his MBA at Durham University, UK. During his career he has led technology & especially inhaler development teams through engineering, CMC characterisation, clinical evidence generation, registration within US, EU and International Markets and ultimately to successful global launch. Total Brand Leadership value >$2.5bn. Mark has numerous patents granted and pending in electronic communications, sports technologies, inhaled pharmaceutical development, and respiratory physiological function & predictive AI. Mark is the inventor of Digihaler®, the first FDA approved digital inhaler with built-in sensors.



Mark Milton-Edwards

Sessions


  • Thursday - May 11, 2023 - 13:30

    Digihaler Inhaler Case Study and Lessons from Air Crashes

      Presentation


  • Thursday - May 11, 2023 - 15:50

    Panel Discussion: Emerging technologies and how pharma-health collaboration works on innovating drug discovery & patient experience

    • Why is it important for pharma and healthcare to work together?
    • The changing patient behaviour in the digital era
    • Why is it essential to be prompt in identifying and addressing the patient’s needs?
    • How will digitization help bring patients on board?
    • Progress made by companies so far
    • Strategies to be adopted to increase patient –company data flow


 

Stay Informed

Subscribe today to receive news on latest updates,
offers and upcoming conferences via email

For general conference and registration enquires please contact the below email id or fill out the form

Enquire now